Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Azacitidine
Related studies linked through entity extraction aliases.
Pacritinib in CMML
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Venetoclax in Combination With Azacitidine (VEN/AZA) Followed by Donor Lymphocyte Infusion (DLI) for Patients With Very High-Risk Acute Myeloid Leukemia (AML) Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)
- Status
- TERMINATED
- Phase
- PHASE1
Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With Higher-risk MDS
- Status
- RECRUITING
- Phase
- PHASE2
Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With AML
- Status
- RECRUITING
- Phase
- PHASE2
Phase I/II Study of SY-1425 (Tamibarotene) in Combination With Azacitidine and Venetoclax for Patients With Chronic Myelomonocytic Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Trial to Assess Cobicistat Boosted Venetoclax in Combination With Azacitidine in Adult Patients With Newly Diagnosed AML
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Lenalidomide Combined With Azacitidine vs Azacitidine in the Treatment of MDS-RS
- Status
- UNKNOWN
- Phase
- PHASE4
Study of BC3402 in Combination With Azacitidine in Patients With MDS and CMML
- Status
- RECRUITING
- Phase
- PHASE1
Chidamide in Combination With Azacitidine, Liposomal Mitoxantrone, and Prednisone (CAMP Regimen) for the Treatment of Previously Untreated Nodal TFH Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia
- Status
- SUSPENDED
- Phase
- PHASE2
An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.
- Status
- RECRUITING
- Phase
- PHASE3
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML)
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1
Chidamide, Azacitidine Combined With GM Regimen for Relapsed and Refractory DLBCL Patients
- Status
- RECRUITING
- Phase
- PHASE2
Magrolimab in Combination with Azacitidine After Allogeneic HCTin Treating Patients with High-Risk AML or MDS
- Status
- WITHDRAWN
- Phase
- PHASE1
Selinexor and HAAG With/Without HMA in Relapsed/Refractory Acute Leukemia (AML) Patients
- Status
- UNKNOWN
- Phase
- NA
A Study Using Subject-specific MRD to Adopt Treatment After HSCT for Subjects With MDS
- Status
- RECRUITING
- Phase
- PHASE2
PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT
- Status
- RECRUITING
- Phase
- NA